Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 93 articles:
HTML format
Text format



Single Articles


    October 2019
  1. TAMARELLE J, Ma B, Gajer P, Humphrys MS, et al
    Non-optimal vaginal microbiota after azithromycin treatment for Chlamydia trachomatis infection.
    J Infect Dis. 2019 Oct 1. pii: 5579997. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2019
  2. TIFREA DF, Pal S, de la Maza LM
    A recombinant Chlamydia trachomatis MOMP vaccine elicits cross-serogroup protection in mice against vaginal shedding and infertility.
    J Infect Dis. 2019 Aug 28. pii: 5555888. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. RACEY CS, Albert A, Donken R, Smith L, et al
    Cervical intraepithelial neoplasia rates in British Columbia women: A population level data linkage evaluation of the school-based HPV immunization program.
    J Infect Dis. 2019 Aug 23. pii: 5553681. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. GODI A, Kemp TJ, Pinto LA, Beddows S, et al
    Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies.
    J Infect Dis. 2019 Aug 15. pii: 5550116. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2019
  5. WANG H, Ma Y, Li R, Chen X, et al
    Associations of cervicovaginal lactobacilli with high-risk HPV infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis.
    J Infect Dis. 2019 Jun 26. pii: 5523772. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. BOGAARDS JA, van der Weele P, Woestenberg PJ, van Benthem BHB, et al
    Bivalent HPV Vaccine Effectiveness Correlates with Phylogenetic Distance from Hpv Vaccine Types 16 And 18.
    J Infect Dis. 2019 Jun 4. pii: 5511346. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  7. DUKERS-MUIJRERS NHTM, Wolffs PFG, de Vries HJC, Gotz HM, et al
    Viable bacterial load is key to azithromycin treatment failure in rectally Chlamydia trachomatis infected women (FemCure).
    J Infect Dis. 2019 May 20. pii: 5492300. doi: 10.1093.
    PubMed     Text format    


    March 2019
  8. KHOSROPOUR CM, Soge OO, Suchland R, Leipertz G, et al
    Recurrent/intermittent vaginal and rectal chlamydial infection following treatment: a prospective cohort study among female STD clinic patients.
    J Infect Dis. 2019 Mar 12. pii: 5381072. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. POSTON TB, Lee DE, Darville T, Zhong W, et al
    Cervical cytokines associated with Chlamydia trachomatis susceptibility and protection.
    J Infect Dis. 2019 Mar 1. pii: 5367429. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  10. THOMAS JC, Seby S, Abrams AJ, Cartee J, et al
    Evidence of Recent Genomic Evolution in Gonococcal Strains with Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.
    J Infect Dis. 2019 Feb 21. pii: 5351606. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. FOLSCHWEILLER N, Behre U, Dionne M, Durando P, et al
    Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
    J Infect Dis. 2019 Feb 3. pii: 5306135. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  12. WANG Y, Ferrer-Espada R, Baglo Y, Goh XS, et al
    Photo-inactivation of Neisseria gonorrhoeae: A paradigm changing approach for combating antibiotic-resistant gonococcal infection.
    J Infect Dis. 2019 Jan 9. pii: 5283517. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  13. MENA M, Taberna M, Monfil L, Arbyn M, et al
    May oral HPV in healthy individuals explain differences in HPV-attributable fractions in oropharyngeal cancer? A systematic review and meta-analysis.
    J Infect Dis. 2018 Dec 22. pii: 5257869. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  14. ROSENBERG T, Philipsen BB, Mehlum CS, Dyrvig AK, et al
    Therapeutic use of the HPV vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis.
    J Infect Dis. 2018 Oct 25. pii: 5144565. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. BEERNINK PT, Ispasanie E, Lewis LA, Ram S, et al
    A meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and overexpressed Factor H binding protein elicits gonococcal bactericidal antibodies.
    J Infect Dis. 2018 Oct 20. pii: 5139647. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. GRILLOVA L, Noda AA, Lienhard R, Blanco O, et al
    Multilocus sequence typing of Treponema pallidum subsp. pallidum in Cuba from 2012 to 2017.
    J Infect Dis. 2018 Oct 16. pii: 5132979. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  17. FAUST H, Artemchuk H, Ostrbenk A, Triglav T, et al
    Seropositivity to multiple anogenital HPV types is associated with current anogenital HPV infection, abnormal cytology and seropositivity for non-genital HPVs.
    J Infect Dis. 2018 Sep 7. pii: 5092660. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. JI Y, Ma XX, Li Z, Peppelenbosch MP, et al
    The Burden of Human Papillomavirus and Chlamydia trachomatis Coinfection in Women: A Large Cohort Study in Inner Mongolia, China.
    J Infect Dis. 2018 Sep 5. pii: 5091237. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  19. LAZCANO-PONCE E, Torres-Ibarra L, Cruz-Valdez A, Salmeron J, et al
    Persistence of immunity when using different HPV vaccination schedules and booster dose effects at 5 years post-primary vaccination.
    J Infect Dis. 2018 Aug 1. pii: 5063117. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  20. LIU Y, Sigel K, Gaisa MM
    HPV Genotypes Predict Progression of Anal Low-grade Squamous Intraepithelial Lesions.
    J Infect Dis. 2018 Jul 21. pii: 5057008. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. AGYEMANG E, Magaret AS, Selke S, Johnston C, et al
    Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
    J Infect Dis. 2018 Jul 17. pii: 5055244. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. FEIRING B, Laake I, Christiansen IK, Hansen M, et al
    Substantial decline in prevalence of vaccine-type and non-vaccine type HPV in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway.
    J Infect Dis. 2018 Jul 16. pii: 5054086. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. VAN WAGONER N, Fife K, Leone PA, Bernstein DI, et al
    Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-controlled Trial.
    J Infect Dis. 2018 Jul 6. pii: 5049813. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  24. WONG SCC, Au TCC, Chan SCS, Ng LPW, et al
    Menstrual Blood HPV DNA and TAP1 gene Polymorphisms as Potential Biomarkers for Screening and Monitoring of Cervical Squamous Intraepithelial Lesion.
    J Infect Dis. 2018 Jun 19. pii: 5040353. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. MESHER D, Panwar K, Thomas SL, Edmundson C, et al
    The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    J Infect Dis. 2018 Jun 18. pii: 5025126. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. SHIPLEY MM, Renner DW, Ott M, Bloom DC, et al
    Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.
    J Infect Dis. 2018 Jun 18. pii: 5039658. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. GODI A, Martinelli M, Haque M, Li S, et al
    Impact of Naturally Occurring Variation in the Human Papillomavirus (HPV) 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies.
    J Infect Dis. 2018 Jun 13. pii: 5037260. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  28. KELLY H, Faust H, Chikandiwa A, Ngou J, et al
    Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    J Infect Dis. 2018 May 30. pii: 5025554. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. PAMNANI SJ, Sudenga SL, Rollison DE, Ingles DJ, et al
    Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2018 May 24. pii: 5002064. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. MARIAGGI AA, Pere H, Perrier M, Visseaux B, et al
    Presence of HPV APOBEC-related Minority Variants in HPV16 Genomes from Anal and Cervical Samples but not in HPV52 and HPV58.
    J Infect Dis. 2018 May 17. pii: 4997032. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. TWISK DE, van der Sande MAB, van Eeden A, Heideman DAM, et al
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis. 2018 May 16. pii: 4996623. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. GARLAND SM, Pitisuttithum P, Ngan HYS, Cho CH, et al
    Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.
    J Infect Dis. 2018 May 15. pii: 4996119. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  33. SAFAEIAN M, Castellsague X, Hildesheim A, Wacholder S, et al
    Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.
    J Infect Dis. 2018 Apr 30. pii: 4990620. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. GAO K, Shen X, Lin Y, Zhu XZ, et al
    Origin of Nontreponemal Antibodies During Treponema pallidum Infection: Evidence From a Rabbit Model.
    J Infect Dis. 2018 Apr 25. pii: 4985700. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. BRADLEY J, Floyd S, Piwowar-Manning E, Laeyendecker O, et al
    Sexually Transmitted Bedfellows: Exquisite Association between HIV and HSV2 in 21 Communities in Southern Africa in the HPTN 071 (PopART) Study.
    J Infect Dis. 2018 Apr 6. pii: 4962568. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  36. PATEL EU, Grabowski MK, Eisenberg AL, Packman ZR, et al
    Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.
    J Infect Dis. 2018 Mar 23. pii: 4951824. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  37. ARTEMCHUK H, Triglav T, Ostrbenk A, Poljak M, et al
    Seroprevalences for 11 Human Papillomavirus (HPV) Types Mark Cumulative HPV Exposure.
    J Infect Dis. 2018 Feb 26. pii: 4909742. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. KOJIC EM, Conley L, Bush T, Cu-Uvin S, et al
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study
    J Infect Dis. 2018 Feb 14. pii: 4857222. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. LIU Z, Nyitray AG, Hwang LY, Swartz MD, et al
    Acquisition, Persistence, and Clearance of Human Papillomavirus Infection Among Male Virgins Residing in Brazil, Mexico, and the United States.
    J Infect Dis. 2018;217:767-776.
    PubMed     Text format     Abstract available


  40. MACHALEK DA, Garland SM, Brotherton JML, Bateson D, et al
    Very low prevalence of vaccine human papillomavirus (HPV) types among 18 to 35 year old Australian women, nine years following implementation of vaccination.
    J Infect Dis. 2018 Feb 7. pii: 4841780. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. DONKEN R, King AJ, Bogaards JA, Woestenberg PJ, et al
    High effectiveness of the bivalent HPV vaccine up to six years post-vaccination against incident and persistent HPV infections in young Dutch females.
    J Infect Dis. 2018 Feb 2. pii: 4835373. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. POLLOCK KGJ
    Sustained cross-protection of the bivalent HPV vaccine.
    J Infect Dis. 2018 Feb 2. pii: 4835375. doi: 10.1093.
    PubMed     Text format    


    December 2017
  43. TANSEY C, Zhao C, Hopkins A, Ritter JM, et al
    A Non-human Primate Model for Rectally Transmitted Syphilis.
    J Infect Dis. 2017 Dec 22. pii: 4772175. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. EASTMAN AJ, Bergin IL, Chai D, Bassis CM, et al
    Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
    J Infect Dis. 2017 Dec 15. pii: 4743781. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  47. SCHERER EM, Smith RA, Carter JJ, Wipf GC, et al
    Analysis of memory B cell responses reveals suboptimal dosing schedule of a licensed vaccine.
    J Infect Dis. 2017 Nov 24. pii: 4657105. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. BAVOIL PM, Marques PX, Brotman R, Ravel J, et al
    Does Active Oral Sex Contribute to Female Infertility?
    J Infect Dis. 2017;216:932-935.
    PubMed     Text format     Abstract available


  50. WOESTENBERG PJ, King AJ, van Benthem BHB, Donken R, et al
    Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors.
    J Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. NOVAKOVIC D, Cheng ATL, Zurynski Y, Booy R, et al
    A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.
    J Infect Dis. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. DONOVAN B, Callander D
    Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue.
    J Infect Dis. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format    


    September 2017
  53. PODDIGHE D
    2-Dose Schedule of AS04-Adjuvanted Human Papillomavirus Types 16/18 Vaccine.
    J Infect Dis. 2017;216:782-783.
    PubMed     Text format    


  54. DROLET M, Laprise JF, Brotherton JML, Donovan B, et al
    The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and post-vaccination data interpretation.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. MALAGON T, Burchell AN, El-Zein M, Guenoun J, et al
    Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviours.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. RYSER MD, Rositch A, Gravitt PE
    Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
    J Infect Dis. 2017;216:604-611.
    PubMed     Text format     Abstract available


  57. OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
    Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    J Infect Dis. 2017;216:594-603.
    PubMed     Text format     Abstract available


    August 2017
  58. TUITE AR, Gift TL, Chesson HW, Hsu K, et al
    Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea.
    J Infect Dis. 2017 Aug 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. LEHTINEN T, Soderlund-Strand A, Petaja T, Eriksson T, et al
    Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination.
    J Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    PubMed     Text format     Abstract available


  61. BAUSSANO I, Lazzarato F, Ronco G, Lehtinen M, et al
    Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.
    J Infect Dis. 2017;216:336-344.
    PubMed     Text format     Abstract available


    July 2017
  62. LEWIS J, Price MJ, Horner PJ, White PJ, et al
    Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established.
    J Infect Dis. 2017;216:237-244.
    PubMed     Text format     Abstract available


  63. GOLDEN MR, Workowski KA, Bolan G
    Developing a Public Health Response to Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  64. MCGOWIN CL, Totten PA
    The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  65. HAMPRAS SS, Rollison DE, Giuliano AR, McKay-Chopin S, et al
    Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites.
    J Infect Dis. 2017;216:92-96.
    PubMed     Text format     Abstract available


    June 2017
  66. HUANG LM, Puthanakit T, Cheng-Hsun C, Ren-Bin T, et al
    Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
    J Infect Dis. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. QENDRI V, Bogaards JA, Berkhof J
    Health and economic impact of a tender-based gender-neutral HPV16/18 vaccination program in the Netherlands.
    J Infect Dis. 2017 Jun 6. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  68. JORDAN SJ, Olson KM, Barnes S, Wilson LS, et al
    Lower Levels of Cervicovaginal Tryptophan are Associated with Natural Clearance of Chlamydia in Women.
    J Infect Dis. 2017 May 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. STEINAU M, Gorbach P, Gratzer B, Braxton J, et al
    Concordance between Anal and Oral Human Papillomavirus (HPV) Infections Among Young Men Who Have Sex with Men.
    J Infect Dis. 2017 May 15. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  70. BAKSHI R, Gupta K, Jordan SJ, Brown LT, et al
    Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.
    J Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. PATEL EU, Rositch AF, Gravitt PE, Tobian AAR, et al
    Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States.
    J Infect Dis. 2017;215:1207-1211.
    PubMed     Text format     Abstract available


    March 2017
  72. SUCHLAND RJ, Dimond ZE, Putman TE, Rockey DD, et al
    Whole-genome sequencing of repeat-positive, same-serovar Chlamydia trachomatis collected from the female genital tract demonstrate persistent infections and genome stability.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
    J Infect Dis. 2017;215:844-846.
    PubMed     Text format    


  74. KOTTARIDI C, Kyrgiou M, Pouliakis A, Magkana M, et al
    Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
    J Infect Dis. 2017;215:764-771.
    PubMed     Text format     Abstract available


    February 2017
  75. SHANNON B, Gajer P, Yi TJ, Ma B, et al
    Distinct effects of the cervico-vaginal microbiota and herpes simplex type 2 infection on female genital tract immunology.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  76. RODAS PI, Perez D, Jauffret C, Gonzalez Y, et al
    Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
    J Infect Dis. 2017;215:452-455.
    PubMed     Text format     Abstract available


    January 2017
  77. BERNSTEIN DI, Wald A, Warren T, Fife K, et al
    Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  78. FLORES-DIAZ E, Sereday KA, Ferreira S, Sirak B, et al
    HPV-6 molecular variants association with the development of genital warts in men: The HIM Study.
    J Infect Dis. 2016 Dec 23. pii: jiw600. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. DONKEN R, Schurink-van 't Klooster TM, Schepp RM, van der Klis FR, et al
    Immune responses after two- versus three-doses of HPV vaccination up to 4(1/2) years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D).
    J Infect Dis. 2016 Dec 23. pii: jiw588. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    PubMed     Text format     Abstract available


  81. GRABOWSKI MK, Gravitt PE, Gray RH, Serwadda D, et al
    Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda.
    J Infect Dis. 2016 Dec 23. pii: jiw631. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Text format     Abstract available


  83. GEORGE Z, Omosun Y, Azenabor AA, Partin J, et al
    The roles of unfolded protein response pathways in Chlamydia pathogenesis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  84. BERENSON AB, Laz TH, Rahman M
    Reduction in vaccine-type human papillomavirus prevalence among adult females in the United States, 2009-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  85. MACHALEK DA, Chow EP, Garland SM, Wigan R, et al
    Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  86. SCHLECHT NF, Diaz A, Shankar V, Szporn AH, et al
    RISK OF DELAYED HPV VACCINATION IN INNER-CITY ADOLESCENT WOMEN.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  87. RUSSELL AN, Zheng X, O'Connell CM, Wiesenfeld HC, et al
    Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  88. GRAD YH, Harris SR, Kirkcaldy RD, Green AG, et al
    Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  89. SHAFER WM
    Does the cervicovaginal microbiome facilitate transmission of Neisseria gonorrhoeae from women to men? Implications for understanding transmission of gonorrhea and advancing vaccine development.
    J Infect Dis. 2016.
    PubMed     Text format    


    June 2016
  90. MATTHIJSSE SM, Hontelez JA, Naber SK, Rozemeijer K, et al
    Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  91. MILMAN N, Zhu J, Johnston C, Cheng A, et al
    In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  92. RADZIO J, Henning T, Jenkins L, Ellis S, et al
    Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C. trachomatis and T. vaginalis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  93. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: